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Abstract. The human synovial sarcoma-specific transloca­
tion t(X; 18) results in the fusion of the SYT gene on chromo­
some 18 with either one of the Kruppel-associated box (KRAB) 
containing SSX1 or SSX2 genes on the X chromosome, de­
pending on the exact location of the breakpoint within band 
X pll.2 . Screening of a testis cDNA library yielded several 
SSX-positive clones. Subsequent sequence analysis revealed 
that one third of these clones represent an SSX gene that differs 
from both SSX1 and SSX2. This novel member of the family of
KRAB containing SSX genes, which we designated SSX3, is 
90% homologous to SSX1 and 95 % homologous to SSX2 at the 
cDNA level. Somatic cell hybrid analysis indicated that SSX3 
maps within Xpl 1.2-»pi 1.1, the region that also harbors the 
SSX1 and SSX2 genes. However, we conclude from our RT- 
PCR data and from results reported in the literature that SSX3 
does not act as a fusion partner to SYT in any of the 44 inde­
pendent synovial sarcomas thus far tested.
Synovial sarcomas are soft-tissue tumors that occur mainly 
in adolescents and young adults. The chromosomal transloca­
tion t(X; 18)(pl 1.2;ql 1.2) is found in the majority of these sar­
comas and, as such, is thought to play a causative role in tumor 
formation (Turc-Carel et al., 1987). Two distinct chimeric 
products have been identified in different t(X; 18)-positive 
synovial sarcomas, resulting from the fusion of the SYT gene 
on chromosome 18 to either the SSX1 or the SSX2 gene on the 
X chromosome (Clark et al., 1994; Leeuw et al., 1994a, 1995; 
Crew et al., 1995). These alternative fusion products have been 
correlated with different X-chromosomal breakpoints in fluo­
rescence in situ hybridization experiments using Xp 11.2-spe­
cific YACs as probes (Leeuw et al., 1993a, b, 1994b; Olde 
Weghuis et al., 1994; Shipley et al., 1994; Janz et al., 1995). 
Interestingly, there appears to be a positive relationship be­
tween the occurrence of these alternative X-chromosomal 
breakpoints and the most predominant histologic characteris­
tics of the tumors, namely, whether they are monophasic or
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biphasic (Leeuw et al., 1994b; Janz et al., 1995). Here, we 
report the identification and chromosomal localization of a 
third member of the family of Kruppel-associated box contain­
ing SSX genes. This gene, however, is not implicated in t(X; 18)- 
positive synovial sarcomas.
Materials and methods
Library screening and sequence analysis
The human fibrosarcoma HT1080 (Clonetech) and the human testis 5' 
stretch (Clonetech) cDNA libraries were used for screening, using essentially 
the same standard procedures described as before (Leeuw et al., 1993b, 
1994a). DNA sequences were analyzed on an automated DNA sequencer 
(ABI 373A) using a Taq dye deoxy terminator cycle sequencing kit (Applied 
Biosystems).
Patient material and RT-PCR analysis
The patient material used in this study included nine synovial sarcomas 
that were extensively analyzed before (Leeuw et al., 1995) and six novel 
tumors. Diagnosis of these latter six tumors as synovial sarcomas was con­
firmed via a positive SYT-SSX RT-PCR score. RT-PCR and subsequent 
restriction enzyme analyses were performed as described previously (Leeuw 
etal., 1995).
Southern blot analysis
DNAs of hybrid and parental cell lines were isolated as described before 
(Leeuw et al., 1994a); digested to completion with a variety of restriction 
endonucleases (Life Technologies); and, after agarose gel electrophoresis,
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SSX1 ATGAACGGAG ACGACACCTT TGCAAAGAGA CCCAGGGATG 
SSX2 ATGAACGGAG ACGACGCCTT TGCAAGGAGA CCCACGGTTG 
SSX3 ATGAACGGAG ATGACACCTT TGCAAGGAGA CCCACGGTTG
SSX1 ATGCTAAAGC ATCAGAGAAG AGAAGCAAGG CCTTTGATGA 
SSX2 GTGCTCAAAT ACCAGAGAAG ATCCAAAAGG CCTTCGATGA 
SSX3 GTGCTCAAAT ACCAGAGAAG ATACAAAAGG CCTTCGATGA
SSX1 TATTGCCACA TACTTCTCTA AGAAAGAGTG GAAAAAGATG 
SSX2 TATTGCCAAA TACTTCTCTA AGGAAGAGTG GGAAAAGATG 
SSX3 TATTGCCAAA TACTTCTCTA AGGAAGAGTG GGAAAAGATG
SSX1 AAATACTCAG AGAAAATCAG CTATGTGTAT ATGAAGAGAA 
SSX2 AAAGCCTCAG AGAAAATCTT CTATGTGTAT ATGAAGAGAA 
SSX3 AAAGTCTCGG AGAAAATCGT CTATGTGTAT ATGAAGAGAA
SSX1 ACTATAAGGC CATGACTAAA CTAGGTTTCA AAGTCACCCT 
SSX2 AGTATGAGGC TATGACTAAA CTAGGTTTCA AGGCCACCCT 
SSX3 AGTATGAGGC CATGACTAAA CTAGGTTTCA AGGCCATCCT
SSX1 CCCACCTTTC ATGTGTAATA AACAGGCCAC AGACTTCCAG 
SSX2 CCCACCTTTC ATGTGTAATA TACGGGCCGA AGACTTCCAG 
SSX3 CCCATCTTTC ATGCGTAATA AACGGGTCAC AGACTTCCAG
SSX1 GGGAATGATT TTGATAATGA CCATAACCGC AGGATTCAGG 
SSX2 GGGAATGATT TGGATAATGA CCCTAACCGT GGGAATCAGG 
SSX3 GGGAATGATT TTGATAATGA CCCTAACCGT GGGAATCAGG
SSX1 TTGAACATCC TCAGATGACT TTCGGCAGGC TCCACAGAAT 
SSX2 TTGAACGTCC TCAGATGACT TTCGGCAGGC TCCAGGGAAT 
SSX3 TTCTACGTCC TCAGATGACT TTCGGCAGGC TCCAGGGAAT
SSX1 CATCCCGAAG ATCATGCCCA AGAAGCCAGC AGAGGACGAA 
SSX2 CTCCCCGAAG ATCATGCCCA AGAAGCCAGC AGAGGAAGGA 
SSX3 CTTCCCGAAG ATCATGCCCA AGAAGCCAGC AGAGGAAGGA
Lt r a n s l o c a t i o n  b r e a k p o in t
Fig. 1 . The SSX3 cDNA sequence compared to those of SSX1 
Bglll, EcoRV, Smal, and Lspl restriction sites are indicated.
SSX l AATGATTCGA AGGGAGTGTC AGAAGCATCT GGCCCACAAA 
SSX2 AATGATTCGG AGGAAGTGCC AGAAGCATCT GGCCCACCAA 
SSX3 AATGTTTCGA AGGAAGTGCC AGAAGCATCT GGCCCACAAA
L s p l
SSX l ACGATGGGAA ACAACTGCAC CCCCCAGGAA AAGCAAATAT 
SSX2 AT GAT G G GAA AGAGCTGTGC CCCCCGGGAA AACCAACTAC 
SSX3 ACGATGGGAA ACAGCTGTGC CCCCCGGGAA AACCAACTAC
Sma I
SSX l TTCTGAGAAG ATTAATAAGA GATCTGGACC CAAAAGGGGG 
SSX2 CTCTGAGAAG ATTCACGAGA GATCTGGACC CAAAAGGGGG 
SSX3 CTCTGAGAAG ATTAACATGA TATCTGGACC CAAAAGGGGG
E coR V /B g lX I
SSX l AAACATGCCT GGACCCACAG ACTGCGTGAG AGAAAGCAGC 
SSX2 GAACATGCCT GGACCCACAG ATTGCGTGAG AGAAAACAGC 
SSX3 GAACATGCCT GGACCCACAG ACTGCGTGAG AGAAAACAGC
SSX l TGGTGATTTA TGAAGAGATC AGCGACCCTG AGGAAGATGA 
SSX2 TGGTGATTTA TGAAGAGATC AGCGACCCTG AGGAAGATGA 
SSX3 TGGTGATTTA TGAAGAGATC AGCGATCCTG AGGAAGATGA
SSX l CGAGTAACTC CCCTGGGGGA TACGACACAT GCCCTTGATG 
SSX2 CGACTAACTC CCCTCAGGGA TACGACACAT GCCCATGATG 
SSX3 TGAGTAACTC CCCTTGGGGA TATGACACAT GCCCATGATG
SSX l AGAAGCAGAA CGTGGTGACC TTTCACGAAC ATGGGCATGG 
SSX2 AGAAGCAGAA CGTGGTGACC TTTCACGAAC ATGGGCATGG 
SSX3 AGAAGCAGAA CGTGGTGACC TTTCACGAAC ATGGGCATGG
SSX l CTGCGGCTCC CTCGTCATCA GGTGCATAGC AAGTG 
SSX2 CTGCGGCTCC CTCGTCATCA GGTGCATAGC AAGTG 
SSX3 CTGTGGACCC CTCGTCATCA GGTGCATAGC AAGTG
Fig. 2. Restriction digests of SSX3 testis cDNA clones (BamHl-Xbal 
inserts into pDR2) using BamHU Bglll (lanes l—5) or BamHl/IuvR'V (lanes 
6-10). Lanes 1 and 6: pDR2-30; lanes 2 and 7: pDR2-33; lanes 3 and 8: 
pDR2-34; lanes 4 and 9: pDR2-36; lanes 5 and 10: pDR2-42. Lane M: size 
marker (100-bp ladder, Life Technologies). The 6()0-bp marker band is indi­
cated by an arrow. The asterisks indicate a 1.3-kb Baml-l if EcoRV vector
M 1 2 3 4 5 6 7 8 9 10 M
*
blotted onto Genescreen Plus membranes (Dupont) using standard proto- these fragments was used as a probe to screen a human testis
cols. Blots were hybridized overnight in 0.5 mM PBS, 1 mM NaaEDTA, and 
7% (h’/ vJ SDS at 65 °C; washed once in 40 mM phosphate, 0.1 % SDS and 
then in 10 mM phosphate, 0.1 % SDS at 650 C; and, lastly, exposed to X-ray 
film (Kodak) at -8 0 °C  for 1-3 d, using intensifying screens.
cDNA library, which resulted in 15 positive clones. Five of 
these full-length clones (pDR2-30, pDR2-33, pDR2-34, pDR2- 
36, and pDR2-42) were found to lack a Bglll site that is normal­
ly present in both the SSXl and SSX2 cDNAs (Leeuw et al., 
1995). Sequencing of these five clones yielded identical results 
and revealed a novel SSX transcript that was significantly dif­
ferent from SSXl and SSX2 (for comparison, see Fig. 1). Over- 
Screening of a human fibrosarcoma cDNA library with a all, this novel sequence, which we designated SSX3, is 90% 
synovial sarcoma-derived SYT-SSX RT-PCR product (Leeuw homologous to SSXl and 95% homologous to SSX2 at the 
et al., 1995) yielded several partial SSX2 fragments. One of cDNA level. At the position of the Bglll site in SSXl and SSX2
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synovial sarcomas revealed a Bglll site and either an Sma\ or 
Lspl site, whereas none showed an EcoRV site or both ¿7««I 
and Lspl sites (Fig. 3). From these results we conclude that the 
SSX3 gene is not fused to SYT in any of our 15 independent 
synovial sarcomas.
FI*. 3. Restric tion <liecst „fSY T-ssx R T -P C R  products from !2d iiT Cr- C r e w ct a1' (1995) P“ 1* "  a  series o f 2 9  synovial sa rco m as
ent synovial sarcomas with EcoRV (A), Bglll (B), Lspl (C), and Smal (D). The
PCR was performed on 1 jxl of RT material with SYT (5'-CAACAGCAA- SSX RT-PCR products, but never both sites 
GATGCATACCA-3') and SSX (5'-CAClTGCTATGCACCTGATG-3') tioned that only SSXl or SSX2 sequences were encountered.
primers (Leeuw et al., 1995), I min at 92°C, 1 min at 48°C, and 3 min at 
72“C for 35 cycles. Lanes 1-12 contain RT-PCR material from tumors 94- 
50418, 89-52115, 2374/90, CATC, 88-50654, 243090, Hiss, KN, PTN SSI,
4873/92, 950501XC, and 2214-287, respectively (Leeuw et al., 1993a,
? 1 f t\
Therefore, we conclude that SSX3 is not included in the fusion 
with SYT in any of the 44 independent synovial sarcomas thus 
far tested. In addition, three synovial sarcomas without any evi-
1993b, 1994a, 1994b, 1995; Janz et al., 1995; and unpublished cases). Lane deuce for the presence of SYT-SSX1 or S YT-SSX2 fusion prod-
M: size marker (100-bp ladder, Life Technologies). The 600-bp marker band 
is indicated by an arrow.
ucts were ted (Crew et al.,
ty, but it 
would h
in these cases 
with certain-
detected by the investigators using the highly
(Figs. I and 2) an EcoRV site is found in SSX3 that is not Figure4 compares the amino acid sequences of SSXl,
present in SSX 1 and SSX2. Aside from these differences, SSX3 SSX2, and SSX3. It can be deduced from this comparison that,
shows the same Smal site as SSX2 (absent from SSXl) and the at this level, the identity between SSX2 and SSX3 is relatively
same Lspl site as SSX 1 (absent from SSX2). As a consequence, high (90 %), except for the Kruppel-assoeiated box B (KRAB B)
digestion of SYT-SSX RT-PCR products must reveal Bglll and region, where it is only 73%. The overall identity between
Lspl sites in case SSXl is involved, Bglll and Smal sites in case SSXl and SSX2 is only 76%. Whereas the KRAB A domain
SSX2 is involved, and Smal, Lsph and EcoRV sites in case appears to be involved in the repression of transcription,
B domain seems to be dispensable f
digestion of SYT-SSX RT-PCR products from nine different activity under in vitro conditions ( Witzgall et al., 1994). It 
synovial sarcomas revealed fusion products that contained only been suggested that KRAB-eontaining proteins may exert their 
SSX 1- or SSX2-derived sequences (Leeuw et al., 1995). Diges- effects through interactions with transcriptional activators con- 
tion of RT-PCR products from six additional independent taining a glutamine-rich activation domain (Licht et al., 1993).
« j j tM * % íis a t3 * « í ia  M N s # * i» w s 5 T W * y « w tf4 » * ! tiA U « ^ iP i¿ ^ * > rv y t^ X r» » u ¿ tA ^ iy M $ * n i.?ía
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A B C D E have arisen by reversed transcription. In this respect, they are
different from, for the interspersed OAT-like se-
Fig. 5. Southern blot analysis of 
¿scoRI-digested somatic cell hybrid 
(578, 578K17, Hlsynsarc; lanes C, 
D, and E, respectively) and control 
Chinese hamster (A3, lane A) and 
human (HL60, lane B) cell line 
DNAs. Size markers are deduced 
from a co-electrophoresed 1 -kb lad­
der (BRL).
quences, some of which have been reported to be processed 
pseudogenes (Lafreniere et al., 1991; Geraghty et a l ,  1993). It 
has been hypothesized before that the OATL1 and OATL2 
clusters may have evolved via a duplication event of the entire 
region (Shipley et al., 1994). Our present results indicate that 
during the course of evolution, several of these duplication 
events must have occurred within this particular genomic seg­
ment.
In addition to the SSX3 gene reported here, we have evi­
dence for the existence of at least two other SSX-like genes. The 
first one, designated SSX4, was found after RT-PCR with two 
SSX internal primers oil RNA extracted from a primary human 
fibrosarcoma. Preliminary sequence data indicate that this 
gene may give rise to a protein truncated just after the KRAB A 
box. The second one, SSX5, was detected via the presence of an 
exon in one of our OATL1 YAC-derived cosmids (Leeuw et al., 
1993b). This exon shows between 80% and 90% base-pair 
homology to the corresponding exons in SSX1, SSX2, SSX3, 
and SSX4. Whether SSX4 and SSX5 actually represent func­
tional genes still remains to be established. The possible 
involvement of any of these novel SSX sequences in the devel­
opment of other neoplastic disorders carrying X-autosome 
translocations, such as renal cell carcinomas (Sinke et al., 1993; 
Dijkhuizen et al., 1995), is currently under investigation.
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As such, the observed differences at the amino acid level 
between the KRAB B domains of SSX2 and SSX3 may give rise 
to functionally different interactions. The exact nature of these 
putative interactions, however, remains to be established.
The chromosome location of the SSX3 gene was established 
through the analysis of a panel of human x rodent somatic cell 
hybrids including the X-only line 578 (Sinke et a l, 1993); its 
radiation-reduced derivative 578K17, which contains 
Xp 11.4 -» p 11.1 segment as the only human constituent (Berger 
et al., 1992); and the synovial sarcoma-derived line Hlsynsarc 
containing X p ll .2 -> q te r  (Leeuw et al., 1993a). Since 578, 
578K17, and Hlsynsarc exhibit restricion fragments similar to
in control total human genomic DNA that 
hybridizes to our SSX3 cDNA probe (absent in the control 
hamster DNA under the stringency conditions applied [Fig. 5]), 
we conclude that the SSX3 gene must reside within Xpl 1.2 
p 11.1. This proximal Xp segment contains several low-copy 
repeats, among which are the OAT-like sequences (Sinke et al., 
1993; Leeuw et al., 1994b). Interestingly, SSX1 is positioned 
precisely within the OATL1 cluster (Leeuw et al., 1993a). The 
identification of yet another SSX gene (SSX3) in X p ll.2 ->  
p i 1.1 is in full agreement with the repeated nature of this par­
ticular chromosomal segment (Lafreniere et al., 1991). Since 
SSX1 and SSX2 are functional, expressed genes containing 
intronic sequences (unpublished data), they do not seem to
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